StockWatch
·

Suven Pharmaceuticals Ltd Q4 FY26 Results

COHANCEQ4 FY26 Results
Filing
MetricValue ( Cr)Q3 FY26Q4 FY25
Revenue619.1213.7%54.0%
Total Income617.2812.1%49.6%
Expenditure580.8615.0%60.9%
PBT19.9151.0%61.4%
Net Profit8.3171.4%78.5%
OPM13.27%3.35pp5.03pp
NPM1.35%3.92pp8.04pp
EPS0.5146.9%69.1%
View full financials

Informational and educational content only. Not investment advice.